Haemonetics Corp (NYSE:HAE)
| 83.01 Delayed Data As of 3:59pm ET |  +0.44 / +0.53%Today’s Change | 48.67 Today|||52-Week Range 91.39 | +5.54% Year-to-Date |
Latest HAE News | Press Releases
Today’s Trading
| Previous close | 82.57 |
| Today’s open | 82.57 |
| Day’s range | 82.52 - 86.04 |
| Volume | 621,898 |
| Average volume (3 months) | 435,007 |
| Market cap | $4.4B |
Data as of 3:59pm ET, 02/08/2023
Growth & Valuation
| Earnings growth (last year) | -45.80% |
| Earnings growth (this year) | +13.07% |
| Earnings growth (next 5 years) | +10.00% |
| Revenue growth (last year) | +14.10% |
| P/E ratio | 44.6 |
| Price/Sales | 3.30 |
| Price/Book | 5.90 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| MMSIMerit Medical System... | -0.08 | -0.11% |
| ICUIICU Medical Inc | -4.00 | -2.11% |
| IARTIntegra Lifesciences... | +0.35 | +0.59% |
| ---- |
Data as of 3:59pm ET, 02/08/2023
Financials
| Next reporting date | May 9, 2023 |
| EPS forecast (this quarter) | $0.71 |
| Annual revenue (last year) | $993.2M |
| Annual profit (last year) | $43.4M |
| Net profit margin | 4.37% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Boston, Massachusetts |
Forecasts
